// App-Quantinova.ai

e15548 : The real life outcomes of modified docetaxel and cisplatin plus fluorourasil regimen in patients with metastatic gastric cancer.

Researchers

Presenter

  • Tulay Eren

Principal Investigators

  • Nuriye Ozdemir Yildirim

  • Ozan Yazici

  • Goksen Inanc Imamoglu

  • Dogan Yazilitas

  • Suheyla Aytac

  • Nurullah Zengin

Medical Centers

  • Diskapi Yildirim Beyazit Research and Training Hospital Department of Medical Oncology, Ankara, Turkey

  • Ankara University Department of Medical Oncology, Ankara, Turkey

  • Ankara Numune Education and Research Hospital, Ankara, Turkey

  • Diskapi Yildirim Beyazit Devlet Hastanesi, Ankara, Turkey

  • Diskapi Yildirim Beyazit Research Hospital, Ankara, Turkey

  • Ankara University Department of Medical Oncology, Ankara, Turkey

  • Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Adrucil injection

  • Docetaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved